Top Markets
#1 Trillions Trillions +5,128.37%
#2 DeFiChain DeFiChain +1,700.88%
#3 Bedrock Bedrock +163.86%
#4 Siren Siren +91.29%
#5 KONET KONET +60.65%
#6 inSure DeFi inSure DeFi +59.52%
#7 Banana For Scale Banana For Scale +44.28%
#8 Aria.AI Aria.AI +38.69%
#9 Syndicate Syndicate +37.36%
#10 Janction Janction +32.88%
Coin of the day
Trillions Trillions
設定
言語
日本
通貨
USD
テーマ
Ovoca Bio plc Ovoca Bio plc

Ovoca Bio plc

OVB
株式のランク #99999
Ovoca Bio plc, a clinical-stage biopharmaceutical company, engages in the... Ovoca Bio plc, a clinical-stage biopharmaceutical company, engages in the development and commercialization of novel product candidates for the treatment of female sexual dysfunctions. It is developing BP-101, a medicinal treatment for premenopausal women with hypoactive sexual desire disorder, which is in phase II clinical study in Australia and New Zealand, and in phase III clinical trials in Russia. It also engages in mineral exploration, as well as provides support services. The company was formerly known as Ovoca Gold plc and changed its name to Ovoca Bio plc in July 2018. Ovoca Bio plc was incorporated in 1985 and is based in Dublin, Ireland.
株価
$0.09933121
時価総額
$29.15K
変化（1日）
0.57%
変化（1年）
449.49%
国
IE
取引 Ovoca Bio plc (OVB)

カテゴリー

Healthcare
Ovoca Bio plc（OVB）の発行済株式数
June 2024 時点の発行済株式数 92.84M
Ovoca Bio plc の最新の財務報告および株価によると、現在の発行済株式数は 92.84M です。December 2023 の終わりには、同社は 75.11M 株の発行済株式 を有していました。発行済株式数は、通常、株式分割や自社株買いによって影響を受けます。
Ovoca Bio plc（OVB）の発行済株式数の履歴（2001 ～ 2026）
各年末時点の発行済株式数
年 発行済株式数 変化
2026 (TTM) 92.84M -99.55%
2024 20.72B 27,488.06%
2023 75.11M -7.91%
2022 81.56M 0.00%
2021 81.56M 0.00%
2020 81.56M 0.00%
2019 81.56M 0.00%
2018 81.56M 0.00%
2017 81.56M 0.00%
2016 81.56M 0.00%
2015 81.56M -6.64%
2014 87.36M 0.00%
2013 87.36M 0.00%
2012 87.36M -0.61%
2011 87.90M -0.64%
2010 88.46M 0.00%
2009 88.46M 1.33%
2008 87.30M 28.36%
2007 68.01M 45.51%
2006 46.74M 129.03%
2005 20.41M 194.39%
2004 6.93M 19.17%
2003 5.82M 1.55%
2002 5.73M 3.94%
2001 5.51M 0.00%
類似企業や競合他社の発行済株式数
企業 発行済株式数 差 国
Novo Nordisk A/S Novo Nordisk A/S
Novo Nordisk A/S
NVO.US
 4.45B 4,691.14%
DK
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 253.90M 173.50%
US
Regeneron Pharmaceuticals, Inc. Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
REGN.US
 102.90M 10.84%
US
UCB SA UCB SA
UCB SA
UCB.BR
 190.00M 104.66%
BE
Argenx SE Argenx SE
Argenx SE
ARGX.US
 61.42M -33.84%
NL